Neuronal activity‐dependent increase of net matrix metalloproteinase activity is associated with MMP‐9 neurotoxicity after kainate
- 22 September 2003
- journal article
- research article
- Published by Wiley in European Journal of Neuroscience
- Vol. 18 (6) , 1507-1517
- https://doi.org/10.1046/j.1460-9568.2003.02876.x
Abstract
Matrix metalloproteinases (MMPs) and the tissue inhibitors of MMPs (TIMPs) are emerging as important modulators of brain physiopathology. Dramatic changes in the expression of MMPs and TIMPs occur during excitotoxic/neuroinflammatory processes. However, only the measurement of net protease activity is relevant physiologically, and the functional consequences of MMP/TIMP ratio modifications in the brain remain elusive. In order to assess MMP activity and effects in brain tissue, we combinedin vivoand organotypic culture models of kainate (KA)‐induced excitotoxicity to provoke selective neuronal death and neuroinflammation in the hippocampus. Usingin situzymography, we show that KA‐induced excitotoxic seizures in rats increase net MMP activity in hippocampal neurons 8 h after seizures, before their death, and that this increase is neuronal activity‐dependent. Three days after KA, proteolytic activity increases in blood vessels and reactive glial cells of vulnerable areas, in relation with neuroinflammation. At 7 and 15 days, proteolysis remains high in blood vessels whereas it is reduced in glia. In organotypic hippocampal cultures, which lack blood cell‐mediated inflammation and extrinsic connections, a broad‐spectrum inhibitor of MMPs (MMPI), but also a selective MMP‐9 inhibitor, protect hippocampal neurons against KA‐induced excitotoxicity. Moreover, recombinant MMP‐9, but not MMP‐2, induces selective pyramidal cell death in these cultures and KA‐induced neuronal activity exacerbates the neuronal death promoting effects of MMP‐9. These data strongly implicate MMPs, and MMP‐9 in particular, in both excitotoxic neuronal damage and subsequent neuroinflammatory processes, and suggest that selective MMPIs could be therapeutically relevant in related neurological disorders.Keywords
This publication has 41 references indexed in Scilit:
- S-Nitrosylation of Matrix Metalloproteinases: Signaling Pathway to Neuronal Cell DeathScience, 2002
- Protease degradomics: A new challenge for proteomicsNature Reviews Molecular Cell Biology, 2002
- Solid-phase synthesis of α-substituted 3-bisarylthio N-Hydroxy propionamides as Specific MMP InhibitorsBioorganic & Medicinal Chemistry, 2002
- Role for Matrix Metalloproteinase 9 after Focal Cerebral Ischemia: Effects of Gene Knockout and Enzyme Inhibition with BB-94Journal of Cerebral Blood Flow & Metabolism, 2000
- Matrix Metalloproteinases and TIMPs Are Associated With Blood-Brain Barrier Opening After Reperfusion in Rat BrainStroke, 1998
- Matrix Metalloproteinase Inhibition as a Novel Anticancer Strategy: A Review with Special Focus on Batimastat and MarimastatPharmacology & Therapeutics, 1997
- Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activatorNature, 1995
- The 84‐kDa Form of Human Matrix Metalloproteinase‐9 Degrades Substance P and GelatinJournal of Neurochemistry, 1995
- Nitric oxide promotes seizure activity in kainate-treated ratsNeuroReport, 1994
- Numerous candidate plasticity-related genes revealed by differential cDNA cloningNature, 1993